Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-32.44	18.19	26.93
Graham Fair Price	302.03	54.58	13.58
PEG	-99.60	< 0.005	-1.22
Price/Book	1.38	1.17	1.16
Price/Cash Flow	-45.89	24.26	44.83
Prices/Earnings	-93.50	7.43	114.28
Price/Sales	8.34	3.09	2.85
Price/FCF	-45.89	24.26	44.83
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	63.03	0.17	0.10
Operating Margin	153.23	0.12	0.05
ROA	1475.30	0.02	< 0.005
ROE	< 0.005	0.04	1459.25
ROIC	< 0.005	0.02	470.02
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.02	< 0.005	-167.48
Dividends QOQ	0.03	0.02	-16.62
EBIT QOQ	-0.71	1.37	92.67
EPS QOQ	-0.93	15.36	1544.85
FCF QOQ	-0.32	0.87	173.30
Revenue QOQ	< 0.005	-0.06	-669.51
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	34.43	40.32	17.10
Days Sales Outstanding (DSO)	63.33	67.57	6.69
Inventory Turnover	2.61	2.23	-14.61
Debt/Capitalization	0.24	0.22	-7.21
Quick Ratio	0.96	0.99	3.17
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	56.91	57.94	1.81
Cash	11.82	12.41	4.92
Capex	-2.12	-1.24	41.77
Free Cash Flow	1.47	2.80	90.76
Revenue	23.09	22.00	-4.72
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.40	1.41	0.62
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	4.45	2.81	-36.88
Naive Interpretation	Member

06 - Financial Health · Weak

Rating